Literature DB >> 26227016

Gender differences in use of prescription narcotic medications among living kidney donors.

Krista L Lentine1,2, Ngan N Lam3, Mark A Schnitzler1,2, Amit X Garg4, Huiling Xiao1, Sheila E Leander5, Daniel C Brennan6, Sandra J Taler7, David Axelrod8, Dorry L Segev9.   

Abstract

Prescription narcotic use among living kidney donors is not well described. Using a unique database that integrates national registry identifiers for living kidney donors (1987-2007) in the United States with billing claims from a private health insurer (2000-2007), we identified pharmacy fills for prescription narcotic medications in periods 1-4 and >4 yr post-donation and estimated relative likelihoods of post-donation narcotic use by Cox regression. We also compared narcotic fill rates and medication possession ratios (MPRs, defined as (days of medication supplied)/(days observed)), between donors and age- and sex-matched non-donors. Overall, rates of narcotic medication fills were 32.3 and 32.4 per 100 person-years in periods 1-4 and >4 yr post-donation. After age and race adjustment, women were approximately twice as likely as men to fill a narcotic prescription in years 1-4 (adjusted hazard ratio, aHR, 2.28; 95% confidence interval, CI, 1.86-2.79) and >4 yr (aHR 1.70; 95% CI 1.50-1.93). MPRs in donors were low (<2.5% days exposed), and lower than among age- and sex-matched non-donors. Prescription narcotic medication use is more common among women than men in the intermediate term after live kidney donation. Overall, total narcotic exposure is low, and lower than among non-donors from the general population.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  administrative claims data; health outcomes; living kidney donors; narcotic medication; pharmacy claims

Mesh:

Substances:

Year:  2015        PMID: 26227016      PMCID: PMC4805522          DOI: 10.1111/ctr.12599

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  53 in total

1.  Better understanding live donor risk through big data.

Authors:  Krista L Lentine; Dorry L Segev
Journal:  Clin J Am Soc Nephrol       Date:  2013-09-26       Impact factor: 8.237

2.  Gout after living kidney donation: a matched cohort study.

Authors:  Ngan N Lam; Eric McArthur; S Joseph Kim; G V Ramesh Prasad; Krista L Lentine; Peter P Reese; Bertram L Kasiske; Charmaine E Lok; Liane S Feldman; Amit X Garg
Journal:  Am J Kidney Dis       Date:  2015-03-25       Impact factor: 8.860

3.  A prospective study on living related kidney donors' quality of life in the first year: choosing appropriate reference data.

Authors:  Sylvia Kroencke; Lutz Fischer; Björn Nashan; Lena Herich; Karl-Heinz Schulz
Journal:  Clin Transplant       Date:  2012 Jul-Aug       Impact factor: 2.863

4.  Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study.

Authors:  C R Gross; E E Messersmith; B A Hong; S G Jowsey; C Jacobs; B W Gillespie; S J Taler; A J Matas; A Leichtman; R M Merion; H N Ibrahim
Journal:  Am J Transplant       Date:  2013-09-06       Impact factor: 8.086

5.  The long-term quality of life of living kidney donors: a multicenter cohort study.

Authors:  K Clemens; N Boudville; M A Dew; C Geddes; J S Gill; V Jassal; S Klarenbach; G Knoll; N Muirhead; G V R Prasad; L Storsley; D Treleaven; A X Garg; A Garg
Journal:  Am J Transplant       Date:  2011-03       Impact factor: 8.086

6.  Maternal treatment with opioid analgesics and risk for birth defects.

Authors:  Cheryl S Broussard; Sonja A Rasmussen; Jennita Reefhuis; Jan M Friedman; Michael W Jann; Tiffany Riehle-Colarusso; Margaret A Honein
Journal:  Am J Obstet Gynecol       Date:  2011-02-23       Impact factor: 8.661

Review 7.  Opioids in chronic non-cancer pain: systematic review of efficacy and safety.

Authors:  Eija Kalso; Jayne E Edwards; Andrew R Moore; Henry J McQuay
Journal:  Pain       Date:  2004-12       Impact factor: 6.961

Review 8.  Opioid epidemic in the United States.

Authors:  Laxmaiah Manchikanti; Standiford Helm; Bert Fellows; Jeffrey W Janata; Vidyasagar Pampati; Jay S Grider; Mark V Boswell
Journal:  Pain Physician       Date:  2012-07       Impact factor: 4.965

9.  Sex Differences in Pain and Pain-Related Disability among Primary Care Patients with Chronic Musculoskeletal Pain.

Authors:  Dawana Stubbs; Erin Krebs; Matthew Bair; Teresa Damush; Jingwei Wu; Jason Sutherland; Kurt Kroenke
Journal:  Pain Med       Date:  2009-12-09       Impact factor: 3.750

10.  Understanding antihypertensive medication use after living kidney donation through linked national registry and pharmacy claims data.

Authors:  Krista L Lentine; Mark A Schnitzler; Amit X Garg; Huiling Xiao; David Axelrod; Janet E Tuttle-Newhall; Daniel C Brennan; Dorry L Segev
Journal:  Am J Nephrol       Date:  2014-09-02       Impact factor: 3.754

View more
  6 in total

1.  Antidepressant medication use before and after kidney transplant: implications for outcomes - a retrospective study.

Authors:  Krista L Lentine; Abhijit S Naik; Rosemary Ouseph; Zidong Zhang; David A Axelrod; Dorry L Segev; Vikas R Dharnidharka; Daniel C Brennan; Henry Randall; Raj Gadi; Ngan N Lam; Gregory P Hess; Bertram L Kasiske; Mark A Schnitzler
Journal:  Transpl Int       Date:  2017-08-03       Impact factor: 3.782

2.  Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records.

Authors:  Krista L Lentine; Farrukh M Koraishy; Nagaraju Sarabu; Abhijit S Naik; Ngan N Lam; Amit X Garg; David Axelrod; Zidong Zhang; Gregory P Hess; Bertram L Kasiske; Dorry L Segev; Macey L Henderson; Allan B Massie; Courtenay M Holscher; Mark A Schnitzler
Journal:  Clin Transplant       Date:  2019-09-08       Impact factor: 2.863

3.  Diabetes Mellitus in Living Pancreas Donors: Use of Integrated National Registry and Pharmacy Claims Data to Characterize Donation-Related Health Outcomes.

Authors:  Ngan N Lam; Mark A Schnitzler; Dorry L Segev; Gregory P Hess; Bertram L Kasiske; Henry B Randall; David Axelrod; Huiling Xiao; Amit X Garg; Daniel C Brennan; Krista L Lentine
Journal:  Transplantation       Date:  2017-06       Impact factor: 4.939

Review 4.  Risks of Living Kidney Donation: Current State of Knowledge on Outcomes Important to Donors.

Authors:  Krista L Lentine; Ngan N Lam; Dorry L Segev
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-11       Impact factor: 8.237

5.  Prescription patterns of opioids and non-steroidal anti-inflammatory drugs in the first year after living kidney donation: An analysis of U.S. Registry and Pharmacy fill records.

Authors:  Luke S Vest; Nagaraju Sarabu; Farrukh M Koraishy; Minh-Tri Nguyen; Meyeon Park; Ngan N Lam; Mark A Schnitzler; David Axelrod; Chi Yuan Hsu; Amit X Garg; Dorry L Segev; Allan B Massie; Gregory P Hess; Bertram L Kasiske; Krista L Lentine
Journal:  Clin Transplant       Date:  2020-06-29       Impact factor: 2.863

6.  Validation of Living Donor Nephrectomy Codes.

Authors:  Ngan N Lam; Krista L Lentine; Scott Klarenbach; Manish M Sood; Paul J Kuwornu; Kyla L Naylor; Gregory A Knoll; S Joseph Kim; Ann Young; Amit X Garg
Journal:  Can J Kidney Health Dis       Date:  2018-04-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.